HAYWARD, Calif.–(BUSINESS WIRE)–Aarvik Therapeutics, an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer therapy, is pleased to announce that it has successfully closed a Series Seed 2 financing round. Aarvik Therapeutics has…
HAYWARD, Calif.–(BUSINESS WIRE)–Aarvik Therapeutics, an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer therapy, is pleased to announce an investment by Laurus Labs, India in Aarvik’s recently-concluded Series Seed 2 financing round. Aarvik’s Series Seed…
Fremont, CA – According to filings with the U.S. Securities and Exchange Commission, Aarvik Therapeutics is raising $8,333,333.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jagath Junutula played a…